Symbiotec Pharmalab Limited (NSE:SYMBIOTEC)

India · Delayed Price · Currency is INR

1,198.00

+21.25 (1.81%)

At close: Oct 1, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Manufacturing of Active Pharmaceuticals Ingredients (API) and Intermediates	8.69B	7.52B	7.16B	5.67B	6.82B
Total	8.69B	7.52B	7.16B	5.67B	6.82B

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	2.87B	3.37B	2.87B	2.67B	3.22B
Europe	2.53B	2.27B	2.12B	-	-
United States	1.14B	302.02M	642.60M	-	-
Rest of World	2.16B	1.57B	1.53B	-	-
outside India	-	-	-	2.99B	3.60B
Total	8.69B	7.52B	7.16B	5.67B	6.82B